Agenus reported $429.02M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US USD 429.02M 27.15M
Amgen AMGN:US USD 63.7B 4.41B
AstraZeneca AZN:LN USD 94.18B 2.39B
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Celldex Therapeutics CLDX:US USD 369.23M 33.74M
CSL CSL:AU USD 28.35B 4.91B
Dynavax Technologies DVAX:US USD 999.34M 23.66M
Eli Lilly And LLY:US USD 47.46B 397.9M
Genocea Biosciences GNCA:US USD 38.79M 17.18M
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Glaxosmithkline GSK:US GBP 60.31B 28.73B
Immunogen IMGN:US USD 358.8M 63.5M
Intrexon XON:US USD 259.24M 61.98M
Jiangsu Hengrui Me. 600276:CH CNY 40.18B 570.88M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Macrogenics MGNX:US USD 195.35M 22.7M
Merck MRK:GR EUR 50.93B 2.22B
Northwest Biotherapeutics NWBO:US USD 31.1M 3.58M
Novartis NOVN:VX USD 118.46B 4.45B
Novavax NVAX:US USD 2.27B 355.56M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Veracyte VCYT:US USD 1.13B 18.24M
YTE INCY:US USD 5.51B 191.18M